Title : Evaluation of drug-drug interactions for oncology therapies: in vitro-in vivo extrapolation model-based risk assessment.

Pub. Date : 2015 Jun

PMID : 25443889






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Quantifying victim DDI potential was also demonstrated using fmCYP3A estimates from ketoconazole clinical DDI studies to predict the magnitude of interaction on co-administration with the CYP3A inducer, rifampicin (1.6-3.3 fold error). Ketoconazole cytochrome P450 family 3 subfamily A member 4 Homo sapiens